HIV-1 Vaccine Trials: Evolving Concepts and Designs

An effective prophylactic HIV-1 vaccine is needed to eradicate the HIV/AIDS pandemic but designing such a vaccine is a challenge. Despite many advances in vaccine technology and approaches to generate both humoral and cellular immune responses, major phase-II and -III vaccine trials against HIV/AIDS...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanou, Missa P, De Groot, Anne S, Murphey-Corb, Michael, Levy, Jay A, Yamamoto, Janet K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534440/
https://www.ncbi.nlm.nih.gov/pubmed/23289052
http://dx.doi.org/10.2174/1874613601206010274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534440/
https://www.ncbi.nlm.nih.gov/pubmed/23289052
http://dx.doi.org/10.2174/1874613601206010274

Ejemplares similares